IDXX - IDEXX Laboratories Non-GAAP EPS of $2.23 beats by $0.19 revenue of $841.66M beats by $11.66M
- IDEXX Laboratories press release ( NASDAQ: IDXX ): Q3 Non-GAAP EPS of $2.23 beats by $0.19 .
- Revenue of $841.66M (+3.9% Y/Y) beats by $11.66M .
- FY2022 Outlook: Revenue of $3.325B to $3.265B vs. prior view of $3.305B to $3.385B and consensus of $3.37B; operating margins of 26.3% to 26.8%; EPS outlook of $7.74 to $7.98 vs. prior outlook of $7.77 - $8.05 and consensus of $7.95.
For further details see:
IDEXX Laboratories Non-GAAP EPS of $2.23 beats by $0.19, revenue of $841.66M beats by $11.66M